Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease
Authors not listed
University Hospitals Cleveland Medical Center · 2012
Abstract
This is an open label study of isotretinoin, a medication which is FDA approved for treatment of other conditions to determine initial safety in Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2012). Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease. <em>University Hospitals Cleveland Medical Center</em>. https://clinicaltrials.gov/study/NCT01560585
Vancouver
Anonymous. Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease. University Hospitals Cleveland Medical Center. 2012.
BibTeX
@misc{anon2012OpenLa,
title = {Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease},
author = {Anonymous},
journal = {University Hospitals Cleveland Medical Center},
year = {2012},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Shanghai Greenvalley Pharmaceutical Co., Ltd. 2011
Open access · US-GOV
Phase II Study of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer Disease
Anavex Life Sciences Corp. 2016
Open access · US-GOV
An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease
Memory Pharmaceuticals 2005
Open access · US-GOV
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MEM 1003 in Patients With Mild to Moderate Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 2009
Open access · US-GOV
A Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild-to-Moderate Alzheimer's Disease
Florida Atlantic University 2007
Open access · US-GOV
Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease
Memory Pharmaceuticals 2007
Open access · US-GOV